PhaseBio Pharmaceuticals' Convertible Note - II Round

PhaseBio Pharmaceuticals raised a round of funding on November 29, 2017.

PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company developing drugs to treat diabetes and cardiovascular dysfunction in patients suffering from rare diseases. The Company's discove…

Articles about PhaseBio Pharmaceuticals' Convertible Note - II Round: